Margie L. Clapper
Department of Cancer research
Fox Chase Cancer Center
United States of America
Biography
Margie L. Clapper,Educational Background: PhD, Genetics/Cell Biology, University of Connecticut at Storrs, CT, 1986. BS, Biology, State Univ. College of New York at Oneonta, NY, 1980. Memberships: NCI IRG Subcommittee A for Review of Cancer Centers. Prime Contractor, Division of Cancer Prevention, NCI. External Advisory Board, UCLA-Boston University SPORE in Lung Cancer. Honors & Awards: Alumni of Distinction, 125th Anniversary of the State University of New York, Oneonta, NY, 2014
Research Interest
Genetic mechanisms underlying the development of spontaneous and colitis-associated colorectal cancer. Gene-environment interactions that contribute to racial and gender-based differences in lung cancer susceptibility. Novel image-based strategies for the earliest detection of preneoplasia.
Publications
-
Peng, J., Xu, X., Mace, B. E., Vanderveer, L. A., Workman, L. R., Slifker, M. J., ... & Clapper, M. L. (2012). Estrogen metabolism within the lung and its modulation by tobacco smoke. Carcinogenesis, 34(4), 909-915.
-
Chang, W. C. L., Zenser, T. V., Cooper, H. S., & Clapper, M. L. (2013). Differential response of flat and polypoid colitis-associated colorectal neoplasias to chemopreventive agents and heterocyclic amines. Cancer letters, 334(1), 62-68.
-
Salaün, M., Peng, J., Hensley, H. H., Roder, N., Flieder, D. B., Houlle-Crépin, S., ... & Clapper, M. L. (2015). MMP-13 in-vivo molecular imaging reveals early expression in lung adenocarcinoma. PloS one, 10(7), e0132960.
